A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Dexfenfluramine
Vorapaxar
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Vorapaxar.
Dexfenfluramine
Icosapent ethyl
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Icosapent ethyl.
Dexfenfluramine
Triflusal
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Triflusal.
Dexfenfluramine
Tranilast
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Tranilast.
Dexfenfluramine
Cangrelor
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Cangrelor.
Dexfenfluramine
Prasugrel
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Prasugrel.
Dexfenfluramine
Caplacizumab
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Caplacizumab.
Dexfenfluramine
Andrographolide
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Andrographolide.
Dexfenfluramine
Ibudilast
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Ibudilast.
Dexfenfluramine
Beraprost
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Beraprost.
Dexfenfluramine
Defibrotide
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Defibrotide.
Dexfenfluramine
Tesmilifene
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Tesmilifene.
Dexfenfluramine
Nimesulide
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Nimesulide.
Dexfenfluramine
Resveratrol
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Resveratrol.
Dexfenfluramine
Ridogrel
The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Ridogrel.
Dexfenfluramine
Pralsetinib
Safinamide may decrease the excretion rate of Pralsetinib which could result in a higher serum level.
Dexfenfluramine
Fostemsavir
Safinamide may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Dexfenfluramine
Ripretinib
Safinamide may decrease the excretion rate of Ripretinib which could result in a higher serum level.
Dexfenfluramine
Idelalisib
Safinamide may decrease the excretion rate of Idelalisib which could result in a higher serum level.
Dexfenfluramine
Pralatrexate
Safinamide may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3